OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances in biological and targeted therapies for systemic sclerosis
Erica Mulcaire-Jones, Andrea Hsiu Ling Low, Robyn T. Domsic, et al.
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 4, pp. 325-339
Closed Access | Times Cited: 8
Erica Mulcaire-Jones, Andrea Hsiu Ling Low, Robyn T. Domsic, et al.
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 4, pp. 325-339
Closed Access | Times Cited: 8
Showing 8 citing articles:
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies
Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 10-10
Open Access | Times Cited: 18
Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 10-10
Open Access | Times Cited: 18
Distinct cAMP regulation in scleroderma lung and skin myofibroblasts governs their dedifferentiation via p38α inhibition
Jared D. Baas, John Varga, Carol Feghali‐Bostwick, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Jared D. Baas, John Varga, Carol Feghali‐Bostwick, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Critical Analysis of Cytoplasmic Progression of Inflammatory Signaling Suggests Potential Pharmacologic Targets for Wound Healing and Fibrotic Disorders
Michael L. Samulevich, Liam E. Carman, Brian J. Aneskievich
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2723-2723
Open Access | Times Cited: 2
Michael L. Samulevich, Liam E. Carman, Brian J. Aneskievich
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2723-2723
Open Access | Times Cited: 2
Is cyclophosphamide still the gold standard in early severe rapidly progressive systemic sclerosis?
Corrado Campochiaro, Yannick Allanore, Yolanda Braun‐Moscovici, et al.
Autoimmunity Reviews (2023) Vol. 23, Iss. 1, pp. 103439-103439
Closed Access | Times Cited: 5
Corrado Campochiaro, Yannick Allanore, Yolanda Braun‐Moscovici, et al.
Autoimmunity Reviews (2023) Vol. 23, Iss. 1, pp. 103439-103439
Closed Access | Times Cited: 5
Recent Advances in Treatment of Systemic Sclerosis and Morphea
Noelle Teske, Nicole Fett
American Journal of Clinical Dermatology (2023) Vol. 25, Iss. 2, pp. 213-226
Closed Access | Times Cited: 5
Noelle Teske, Nicole Fett
American Journal of Clinical Dermatology (2023) Vol. 25, Iss. 2, pp. 213-226
Closed Access | Times Cited: 5
Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022
Ivan Foeldvari, Kathryn S. Torok, Jordi Antón, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 4, pp. 387-404
Closed Access | Times Cited: 5
Ivan Foeldvari, Kathryn S. Torok, Jordi Antón, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 4, pp. 387-404
Closed Access | Times Cited: 5
T cells promote distinct transcriptional programs of cutaneous inflammatory disease in human skin structural cells
Hannah A. DeBerg, Mitch L. Fahning, James D. Schlenker, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Hannah A. DeBerg, Mitch L. Fahning, James D. Schlenker, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
IL-21 drives skin and lung inflammation and fibrosis in a model for systemic sclerosis
In Gyu Um, Jin Seok Woo, Young Joon Lee, et al.
Immunology Letters (2024), pp. 106924-106924
Closed Access
In Gyu Um, Jin Seok Woo, Young Joon Lee, et al.
Immunology Letters (2024), pp. 106924-106924
Closed Access
